IFNG and non-small cell lung carcinoma: Another study of NSCLC patients who received ICIs showed low baseline IFN-γ level (<10 IU/ml)and decreased IFN-γ level after ICI treatment was associated with progression disease and immunotherapy-induced pneumonitis (50).